Brooks Laboratories Ltd.
•₹ 60-0.5%
2026-08-21
PROS
- Company is almost debt free
- Operating margins have improved to 8.2% from -10.3%
- Stock looks reasonably valued - P/E of 19.0 is below its historical median
- Company comfortably covers its interest (7.9x coverage)
CONS
- Promoter holding has decreased over last 2 years: -11.0pp
- Company has a low return on capital employed of 4.4%
- Company has a low return on equity of 3.5% over last 3 years
- Recent results are weak - TTM profit is down 12.4% versus prior year
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.20x)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | BROOKS | 59.40 | 13.24 | 174.98 | 0.00 | -1.79 | -101.86 | 22.96 | -9.99 | 21.72 | -5.85 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 | 24 | 22 | 18 | 18 | 21 | 21 | 23 | 26 | 23 | 17 | 20 | 23 | |
| 16 | 23 | 21 | 17 | 18 | 19 | 19 | 22 | 22 | 21 | 16 | 20 | 22 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 1 | 1 | 0 | -0 | 1 | 1 | 2 | 3 | 2 | 0 | 1 | 1 | |
| Tax % | -0.00% | 0.00% | 5.00% | 0.00% | -0.00% | 0.00% | 0.00% | 11.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -1 | 1 | 1 | 0 | -0 | 1 | 1 | 1 | 3 | 2 | 0 | 1 | 1 |
| -0 | 0 | 0 | 0 | -0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | |
| Equity Capital | 25 | 26 | 26 | 26 | 26 | 26 | 26 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 25 | 26 | 26 | 26 | 26 | 26 | 26 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 16
- 16
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -1
- Tax %
- -0.00%
- Net Profit
- -1
- -0
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 24
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 22
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 5.00%
- Net Profit
- 1
- 0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 18
- 17
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 0.00%
- Net Profit
- 0
- 0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 18
- 18
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- -0.00%
- Net Profit
- -0
- -0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 21
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 21
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 23
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 11.61%
- Net Profit
- 1
- 1
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 26
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 0.00%
- Net Profit
- 3
- 1
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 23
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 0.00%
- Net Profit
- 2
- 1
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 17
- 16
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 0.00%
- Net Profit
- 0
- 0
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 20
- 20
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 23
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 1
- 0
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 58 | 56 | 55 | 70 | 77 | 77 | 56 | 79 | 83 | 86 | 83 | |
| 52 | 65 | 63 | 74 | 76 | 75 | 61 | 76 | 81 | 79 | 78 | |
| Operating Profit | 5 | -9 | -5 | -4 | 2 | 3 | -6 | 4 | 6 | 8 | — |
| OPM % | 9 | -16 | -10 | -5 | 2 | 4 | -10 | 5 | 7 | 10 | — |
| Other Income | 0 | 0 | 3 | 0 | 1 | 1 | 0 | 1 | 4 | 1 | 1 |
| Interest | 1 | 2 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 6 | 6 | 7 | 7 | 1 | 2 | 2 | 2 | 2 | 2 |
| 2 | -18 | -15 | -14 | -8 | 1 | -8 | 2 | 3 | 6 | 5 | |
| Tax % | 33 | 21 | 1 | -80 | -85 | 0 | 0 | 2 | 5 | 0 | 0 |
| Net Profit | 2 | -14 | -15 | -24 | -16 | 1 | -8 | 2 | 3 | 6 | 5 |
| EPS | 0 | 0 | 0 | 0 | -6 | 0 | -3 | 1 | 1 | 2 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | -7 | -8 | -10 | -6 | 0 | -3 | 1 | 1 | 2 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | -7 | -8 | -10 | -6 | 0 | -3 | 1 | 1 | 2 | — |
Mar 2017
- 58
- 52
- Operating Profit
- 5
- OPM %
- 9
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 33
- Net Profit
- 2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2018
- 56
- 65
- Operating Profit
- -9
- OPM %
- -16
- Other Income
- 0
- Interest
- 2
- Depreciation
- 6
- -18
- Tax %
- 21
- Net Profit
- -14
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
Mar 2019
- 55
- 63
- Operating Profit
- -5
- OPM %
- -10
- Other Income
- 3
- Interest
- 3
- Depreciation
- 6
- -15
- Tax %
- 1
- Net Profit
- -15
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2020
- 70
- 74
- Operating Profit
- -4
- OPM %
- -5
- Other Income
- 0
- Interest
- 3
- Depreciation
- 7
- -14
- Tax %
- -80
- Net Profit
- -24
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
Mar 2021
- 77
- 76
- Operating Profit
- 2
- OPM %
- 2
- Other Income
- 1
- Interest
- 3
- Depreciation
- 7
- -8
- Tax %
- -85
- Net Profit
- -16
- EPS
- -6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
Mar 2022
- 77
- 75
- Operating Profit
- 3
- OPM %
- 4
- Other Income
- 1
- Interest
- 1
- Depreciation
- 1
- 1
- Tax %
- 0
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2023
- 56
- 61
- Operating Profit
- -6
- OPM %
- -10
- Other Income
- 0
- Interest
- 1
- Depreciation
- 2
- -8
- Tax %
- 0
- Net Profit
- -8
- EPS
- -3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2024
- 79
- 76
- Operating Profit
- 4
- OPM %
- 5
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 2
- Tax %
- 2
- Net Profit
- 2
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2025
- 83
- 81
- Operating Profit
- 6
- OPM %
- 7
- Other Income
- 4
- Interest
- 1
- Depreciation
- 2
- 3
- Tax %
- 5
- Net Profit
- 3
- EPS
- 1
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2026
- 86
- 79
- Operating Profit
- 8
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 6
- Tax %
- 0
- Net Profit
- 6
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
TTM
- 83
- 78
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 5
- Tax %
- 0
- Net Profit
- 5
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 1%
- 5 Years:
- 2%
- 3 Years:
- 16%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- -6%
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- -4%
- 5 Years:
- -12%
- 3 Years:
- -16%
- 1 Year:
- -59%
RETURN ON EQUITY
- 10 Years:
- -7%
- 5 Years:
- 0%
- 3 Years:
- 4%
- Last Year:
- 5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 16 | 16 | 16 | 25 | 25 | 25 | 25 | 26 | 29 | 29 |
| 112 | 98 | 83 | 74 | 40 | 40 | 32 | 43 | 86 | 91 | |
| 3 | 11 | 17 | 15 | 7 | 5 | 6 | 5 | 6 | 6 | |
| Trade Payables | 18 | 27 | 27 | 26 | 13 | 26 | 23 | 15 | 14 | 11 |
| 8 | 9 | 13 | 18 | 8 | 8 | 7 | 4 | 6 | 8 | |
| Total Liabilities | 158 | 162 | 157 | 158 | 93 | 103 | 92 | 94 | 141 | 146 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 125 | 124 | 117 | 113 | 15 | 15 | 15 | 14 | 14 | 15 | |
| Capital Work in Progress | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| 1 | 1 | 0 | 0 | 47 | 47 | 47 | 47 | 91 | 91 | |
| 8 | 11 | 10 | 14 | 12 | 17 | 11 | 10 | 9 | 11 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 20 | 16 | |
| Cash & Bank | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 8 |
| 22 | 23 | 26 | 30 | 18 | 23 | 18 | 7 | 6 | 5 | |
| Total Assets | 158 | 162 | 157 | 158 | 93 | 103 | 92 | 94 | 141 | 146 |
| Total Debt | 14 | 28 | 31 | 27 | 8 | 5 | 6 | 5 | 6 | 7 |
| Net Working Capital | -2 | -10 | -16 | -8 | -0 | 2 | -5 | 8 | 11 | 16 |
| Contingent Liabilities | 20 | 20 | 21 | 21 | 26 | 24 | 20 | 71 | 76 | 123 |
| Book Value per Share | 79.25 | 70.72 | 61.53 | 39.84 | 25.99 | 26.31 | 22.98 | 26.49 | 39.06 | 41.02 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 14 | 28 | 31 | 27 | 8 | 5 | 6 | 5 | 6 | 7 |
| Net Working Capital | -2 | -10 | -16 | -8 | -0 | 2 | -5 | 8 | 11 | 16 |
| Contingent Liabilities | 20 | 20 | 21 | 21 | 26 | 24 | 20 | 71 | 76 | 123 |
| Book Value per Share | 79.25 | 70.72 | 61.53 | 39.84 | 25.99 | 26.31 | 22.98 | 26.49 | 39.06 | 41.02 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2017
- Equity Capital
- 16
- 112
- 3
- Trade Payables
- 18
- 8
- Total Liabilities
- 158
- 125
- Capital Work in Progress
- 0
- 1
- 8
- 0
- Cash & Bank
- 2
- 22
- Total Assets
- 158
- Total Debt
- 14
- Net Working Capital
- -2
- Contingent Liabilities
- 20
- Book Value per Share
- 79.25
- Face Value
- 10.00
- Total Debt
- 14
- Net Working Capital
- -2
- Contingent Liabilities
- 20
- Book Value per Share
- 79.25
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 16
- 98
- 11
- Trade Payables
- 27
- 9
- Total Liabilities
- 162
- 124
- Capital Work in Progress
- 1
- 1
- 11
- 0
- Cash & Bank
- 2
- 23
- Total Assets
- 162
- Total Debt
- 28
- Net Working Capital
- -10
- Contingent Liabilities
- 20
- Book Value per Share
- 70.72
- Face Value
- 10.00
- Total Debt
- 28
- Net Working Capital
- -10
- Contingent Liabilities
- 20
- Book Value per Share
- 70.72
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 16
- 83
- 17
- Trade Payables
- 27
- 13
- Total Liabilities
- 157
- 117
- Capital Work in Progress
- 0
- 0
- 10
- 0
- Cash & Bank
- 3
- 26
- Total Assets
- 157
- Total Debt
- 31
- Net Working Capital
- -16
- Contingent Liabilities
- 21
- Book Value per Share
- 61.53
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- -16
- Contingent Liabilities
- 21
- Book Value per Share
- 61.53
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 25
- 74
- 15
- Trade Payables
- 26
- 18
- Total Liabilities
- 158
- 113
- Capital Work in Progress
- 0
- 0
- 14
- 0
- Cash & Bank
- 2
- 30
- Total Assets
- 158
- Total Debt
- 27
- Net Working Capital
- -8
- Contingent Liabilities
- 21
- Book Value per Share
- 39.84
- Face Value
- 10.00
- Total Debt
- 27
- Net Working Capital
- -8
- Contingent Liabilities
- 21
- Book Value per Share
- 39.84
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 25
- 40
- 7
- Trade Payables
- 13
- 8
- Total Liabilities
- 93
- 15
- Capital Work in Progress
- 0
- 47
- 12
- 0
- Cash & Bank
- 1
- 18
- Total Assets
- 93
- Total Debt
- 8
- Net Working Capital
- -0
- Contingent Liabilities
- 26
- Book Value per Share
- 25.99
- Face Value
- 10.00
- Total Debt
- 8
- Net Working Capital
- -0
- Contingent Liabilities
- 26
- Book Value per Share
- 25.99
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 25
- 40
- 5
- Trade Payables
- 26
- 8
- Total Liabilities
- 103
- 15
- Capital Work in Progress
- 1
- 47
- 17
- 0
- Cash & Bank
- 1
- 23
- Total Assets
- 103
- Total Debt
- 5
- Net Working Capital
- 2
- Contingent Liabilities
- 24
- Book Value per Share
- 26.31
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- 2
- Contingent Liabilities
- 24
- Book Value per Share
- 26.31
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 25
- 32
- 6
- Trade Payables
- 23
- 7
- Total Liabilities
- 92
- 15
- Capital Work in Progress
- 0
- 47
- 11
- 0
- Cash & Bank
- 1
- 18
- Total Assets
- 92
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 20
- Book Value per Share
- 22.98
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 20
- Book Value per Share
- 22.98
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 26
- 43
- 5
- Trade Payables
- 15
- 4
- Total Liabilities
- 94
- 14
- Capital Work in Progress
- 0
- 47
- 10
- 16
- Cash & Bank
- 1
- 7
- Total Assets
- 94
- Total Debt
- 5
- Net Working Capital
- 8
- Contingent Liabilities
- 71
- Book Value per Share
- 26.49
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- 8
- Contingent Liabilities
- 71
- Book Value per Share
- 26.49
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 29
- 86
- 6
- Trade Payables
- 14
- 6
- Total Liabilities
- 141
- 14
- Capital Work in Progress
- 0
- 91
- 9
- 20
- Cash & Bank
- 1
- 6
- Total Assets
- 141
- Total Debt
- 6
- Net Working Capital
- 11
- Contingent Liabilities
- 76
- Book Value per Share
- 39.06
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 11
- Contingent Liabilities
- 76
- Book Value per Share
- 39.06
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 29
- 91
- 6
- Trade Payables
- 11
- 8
- Total Liabilities
- 146
- 15
- Capital Work in Progress
- 1
- 91
- 11
- 16
- Cash & Bank
- 8
- 5
- Total Assets
- 146
- Total Debt
- 7
- Net Working Capital
- 16
- Contingent Liabilities
- 123
- Book Value per Share
- 41.02
- Face Value
- 10.00
- Total Debt
- 7
- Net Working Capital
- 16
- Contingent Liabilities
- 123
- Book Value per Share
- 41.02
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 | -6 | -5 | -9 | -1 | 3 | 1 | -10 | 3 | 9 | |
| Cash from Investing | -17 | -5 | 1 | -2 | -1 | 1 | -0 | 0 | -45 | -3 |
| Cash from Financing | 7 | 12 | 6 | 10 | 1 | -4 | -0 | 10 | 42 | 0 |
| -0 | 1 | 2 | -2 | -0 | 0 | -0 | 0 | -0 | 7 | |
| Free Cash Flow | -8 | -12 | -5 | -10 | -1 | 1 | -0 | -10 | 1 | 7 |
| OCF / Net Profit | 5.74 | 0.45 | 0.34 | 0.39 | 0.06 | 4.69 | -0.07 | -6.41 | 0.86 | 1.60 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -35 | -27 | -16 | -21 | -10 | -2 |
| OCF / Net Profit | 5.74 | 0.45 | 0.34 | 0.39 | 0.06 | 4.69 | -0.07 | -6.41 | 0.86 | 1.60 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -35 | -27 | -16 | -21 | -10 | -2 |
Mar 2017
- 10
- Cash from Investing
- -17
- Cash from Financing
- 7
- -0
- Free Cash Flow
- -8
- OCF / Net Profit
- 5.74
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 5.74
- Cumulative 5-Year FCF
- 0
Mar 2018
- -6
- Cash from Investing
- -5
- Cash from Financing
- 12
- 1
- Free Cash Flow
- -12
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.45
- Cumulative 5-Year FCF
- 0
Mar 2019
- -5
- Cash from Investing
- 1
- Cash from Financing
- 6
- 2
- Free Cash Flow
- -5
- OCF / Net Profit
- 0.34
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.34
- Cumulative 5-Year FCF
- 0
Mar 2020
- -9
- Cash from Investing
- -2
- Cash from Financing
- 10
- -2
- Free Cash Flow
- -10
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.39
- Cumulative 5-Year FCF
- 0
Mar 2021
- -1
- Cash from Investing
- -1
- Cash from Financing
- 1
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -35
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -35
Mar 2022
- 3
- Cash from Investing
- 1
- Cash from Financing
- -4
- 0
- Free Cash Flow
- 1
- OCF / Net Profit
- 4.69
- Cumulative 5-Year FCF
- -27
- OCF / Net Profit
- 4.69
- Cumulative 5-Year FCF
- -27
Mar 2023
- 1
- Cash from Investing
- -0
- Cash from Financing
- -0
- -0
- Free Cash Flow
- -0
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- -16
- OCF / Net Profit
- -0.07
- Cumulative 5-Year FCF
- -16
Mar 2024
- -10
- Cash from Investing
- 0
- Cash from Financing
- 10
- 0
- Free Cash Flow
- -10
- OCF / Net Profit
- -6.41
- Cumulative 5-Year FCF
- -21
- OCF / Net Profit
- -6.41
- Cumulative 5-Year FCF
- -21
Mar 2025
- 3
- Cash from Investing
- -45
- Cash from Financing
- 42
- -0
- Free Cash Flow
- 1
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- -10
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- -10
Mar 2026
- 9
- Cash from Investing
- -3
- Cash from Financing
- 0
- 7
- Free Cash Flow
- 7
- OCF / Net Profit
- 1.60
- Cumulative 5-Year FCF
- -2
- OCF / Net Profit
- 1.60
- Cumulative 5-Year FCF
- -2
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 1.03 | -8.53 | -9.15 | -9.87 | -6.31 | 0.27 | -3.31 | 0.58 | 1.04 | 1.97 |
| Book Value (₹) | 79.25 | 70.72 | 61.53 | 39.84 | 25.99 | 26.31 | 22.98 | 26.49 | 39.06 | 41.02 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 1.70 | -3.76 | -4.24 | -7.11 | -3.41 | 0.86 | -2.59 | 1.26 | 1.58 | 2.51 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 7.96% | -15.26% | -9.97% | -5.05% | 2.47% | 3.67% | -10.26% | 3.85% | 1.66% | 8.23% |
| Net Margin % | 2.57% | -24.27% | -26.90% | -34.98% | -20.17% | 0.87% | -14.73% | 1.92% | 3.70% | 6.77% |
| ROE % | 1.33% | -11.38% | -13.83% | -24.62% | -19.17% | 1.03% | -13.44% | 2.42% | 3.31% | 4.92% |
| ROCE % | 2.59% | -10.64% | -8.60% | -7.77% | -5.24% | 1.87% | -11.21% | 3.50% | 4.35% | 5.33% |
| 1.06% | -8.64% | -9.29% | -15.48% | -12.43% | 0.68% | -8.36% | 1.64% | 2.60% | 4.04% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 83 | 67 | 72 | 71 | 59 | 58 | 91 | 67 | 80 | 77 |
| Inventory Days | 40 | 61 | 71 | 62 | 62 | 69 | 92 | 48 | 42 | 43 |
| Payable Days | 170 | 209 | 249 | 207 | 151 | 145 | 222 | 125 | 98 | 90 |
| -46 | -80 | -106 | -74 | -30 | -18 | -39 | -10 | 24 | 30 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.11x | 0.24x | 0.31x | 0.27x | 0.13x | 0.08x | 0.10x | 0.07x | 0.05x | 0.06x |
| Interest Coverage (x) | 3.46x | -6.29x | -4.05x | -3.03x | -1.60x | 1.99x | -9.67x | 2.84x | 4.14x | 7.95x |
| 0.90x | 0.76x | 0.67x | 0.83x | 0.99x | 1.04x | 0.84x | 1.35x | 1.48x | 1.72x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -28.08% | -3.18% | -1.22% | 26.64% | 10.89% | -0.40% | -27.84% | 43.12% | 3.86% | 3.85% |
| Operating Profit Growth % | -59.16% | -268.17% | 36.84% | 35.91% | 154.19% | 48.12% | -301.95% | 173.22% | 40.36% | 40.51% |
| Net Profit Growth % | -84.32% | -928.65% | -7.19% | -64.64% | 36.05% | 104.27% | -1328.69% | 118.68% | 99.62% | 90.19% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 117.58% | 77.87% | 90.20% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 159.31x | 103.99x | 19.02x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.50x | 2.76x | 0.91x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 59.41x | 55.01x | 13.39x |
Mar 2017
- EPS (₹)
- 1.03
- Book Value (₹)
- 79.25
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.70
- Operating Margin %
- 7.96%
- Net Margin %
- 2.57%
- ROE %
- 1.33%
- ROCE %
- 2.59%
- 1.06%
- Debtor Days
- 83
- Inventory Days
- 40
- Payable Days
- 170
- -46
- Debt to Equity (x)
- 0.11x
- Interest Coverage (x)
- 3.46x
- 0.90x
- Revenue Growth %
- -28.08%
- Operating Profit Growth %
- -59.16%
- Net Profit Growth %
- -84.32%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- -8.53
- Book Value (₹)
- 70.72
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -3.76
- Operating Margin %
- -15.26%
- Net Margin %
- -24.27%
- ROE %
- -11.38%
- ROCE %
- -10.64%
- -8.64%
- Debtor Days
- 67
- Inventory Days
- 61
- Payable Days
- 209
- -80
- Debt to Equity (x)
- 0.24x
- Interest Coverage (x)
- -6.29x
- 0.76x
- Revenue Growth %
- -3.18%
- Operating Profit Growth %
- -268.17%
- Net Profit Growth %
- -928.65%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- -9.15
- Book Value (₹)
- 61.53
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -4.24
- Operating Margin %
- -9.97%
- Net Margin %
- -26.90%
- ROE %
- -13.83%
- ROCE %
- -8.60%
- -9.29%
- Debtor Days
- 72
- Inventory Days
- 71
- Payable Days
- 249
- -106
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- -4.05x
- 0.67x
- Revenue Growth %
- -1.22%
- Operating Profit Growth %
- 36.84%
- Net Profit Growth %
- -7.19%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -9.87
- Book Value (₹)
- 39.84
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -7.11
- Operating Margin %
- -5.05%
- Net Margin %
- -34.98%
- ROE %
- -24.62%
- ROCE %
- -7.77%
- -15.48%
- Debtor Days
- 71
- Inventory Days
- 62
- Payable Days
- 207
- -74
- Debt to Equity (x)
- 0.27x
- Interest Coverage (x)
- -3.03x
- 0.83x
- Revenue Growth %
- 26.64%
- Operating Profit Growth %
- 35.91%
- Net Profit Growth %
- -64.64%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -6.31
- Book Value (₹)
- 25.99
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -3.41
- Operating Margin %
- 2.47%
- Net Margin %
- -20.17%
- ROE %
- -19.17%
- ROCE %
- -5.24%
- -12.43%
- Debtor Days
- 59
- Inventory Days
- 62
- Payable Days
- 151
- -30
- Debt to Equity (x)
- 0.13x
- Interest Coverage (x)
- -1.60x
- 0.99x
- Revenue Growth %
- 10.89%
- Operating Profit Growth %
- 154.19%
- Net Profit Growth %
- 36.05%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 0.27
- Book Value (₹)
- 26.31
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 0.86
- Operating Margin %
- 3.67%
- Net Margin %
- 0.87%
- ROE %
- 1.03%
- ROCE %
- 1.87%
- 0.68%
- Debtor Days
- 58
- Inventory Days
- 69
- Payable Days
- 145
- -18
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 1.99x
- 1.04x
- Revenue Growth %
- -0.40%
- Operating Profit Growth %
- 48.12%
- Net Profit Growth %
- 104.27%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -3.31
- Book Value (₹)
- 22.98
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.59
- Operating Margin %
- -10.26%
- Net Margin %
- -14.73%
- ROE %
- -13.44%
- ROCE %
- -11.21%
- -8.36%
- Debtor Days
- 91
- Inventory Days
- 92
- Payable Days
- 222
- -39
- Debt to Equity (x)
- 0.10x
- Interest Coverage (x)
- -9.67x
- 0.84x
- Revenue Growth %
- -27.84%
- Operating Profit Growth %
- -301.95%
- Net Profit Growth %
- -1328.69%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 0.58
- Book Value (₹)
- 26.49
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.26
- Operating Margin %
- 3.85%
- Net Margin %
- 1.92%
- ROE %
- 2.42%
- ROCE %
- 3.50%
- 1.64%
- Debtor Days
- 67
- Inventory Days
- 48
- Payable Days
- 125
- -10
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 2.84x
- 1.35x
- Revenue Growth %
- 43.12%
- Operating Profit Growth %
- 173.22%
- Net Profit Growth %
- 118.68%
- 117.58%
- P/E (x)
- 159.31x
- P/B (x)
- 3.50x
- Dividend Yield %
- 0.00%
- 59.41x
Mar 2025
- EPS (₹)
- 1.04
- Book Value (₹)
- 39.06
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.58
- Operating Margin %
- 1.66%
- Net Margin %
- 3.70%
- ROE %
- 3.31%
- ROCE %
- 4.35%
- 2.60%
- Debtor Days
- 80
- Inventory Days
- 42
- Payable Days
- 98
- 24
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 4.14x
- 1.48x
- Revenue Growth %
- 3.86%
- Operating Profit Growth %
- 40.36%
- Net Profit Growth %
- 99.62%
- 77.87%
- P/E (x)
- 103.99x
- P/B (x)
- 2.76x
- Dividend Yield %
- 0.00%
- 55.01x
Mar 2026
- EPS (₹)
- 1.97
- Book Value (₹)
- 41.02
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.51
- Operating Margin %
- 8.23%
- Net Margin %
- 6.77%
- ROE %
- 4.92%
- ROCE %
- 5.33%
- 4.04%
- Debtor Days
- 77
- Inventory Days
- 43
- Payable Days
- 90
- 30
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 7.95x
- 1.72x
- Revenue Growth %
- 3.85%
- Operating Profit Growth %
- 40.51%
- Net Profit Growth %
- 90.19%
- 90.20%
- P/E (x)
- 19.02x
- P/B (x)
- 0.91x
- Dividend Yield %
- 0.00%
- 13.39x
Documents
Announcements
- Shareholders meeting
2026-08-21 - Addendum to the Notice of 24th Annual General Meeting of the Company.
- Updates
2026-08-17 - Brooks Laboratories Limited has informed the Exchange regarding 'Intimation Of Record Date, E-Voting Dates And Book Closure Date'.
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.